GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Biosciences Faculty, University of Heidelberg, Heidelberg, Germany.
Front Immunol. 2019 Feb 22;10:219. doi: 10.3389/fimmu.2019.00219. eCollection 2019.
The immunosuppressive tumor microenvironment (TME) established by tumor cells, stromal cells and inhibitory immune cells counteracts the function of tumor reactive T cells. Tumor associated macrophages (TAMs) showing functional plasticity contribute to this process as so called M2-like macrophages can suppress the function of effector T cells and promote their differentiation into regulatory T cells (Tregs). Furthermore, tumor antigen specific CD4 T effector cells can essentially sustain anti-tumoral immune responses as shown for various tumor entities, thus suggesting that cognate interaction between tumor antigen-specific CD4 Th1 cells and TAMs might shift the intra-tumoral M1/M2 ratio toward M1. This study demonstrates repolarization of M2-like PECs upon MHC II-restricted interaction with tumor specific CD4 Th1 cells as shown by extensive gene and protein expression analyses. Moreover, adoptive transfer of OVA-specific OT-II cells into C57BL/6 mice bearing OVA expressing IA tumors resulted in increased accumulation of M1-like TAMs with enhanced M1 associated gene and protein expression profiles. Thus, this paper highlights a so far underestimated function of the CD4 Th1/TAM axis in re-conditioning the immunosuppressive tumor microenvironment.
肿瘤细胞、基质细胞和抑制性免疫细胞共同构成的免疫抑制性肿瘤微环境(TME),会抵消肿瘤反应性 T 细胞的功能。具有功能可塑性的肿瘤相关巨噬细胞(TAMs)在这个过程中发挥作用,因为所谓的 M2 样巨噬细胞可以抑制效应 T 细胞的功能,并促进其向调节性 T 细胞(Tregs)分化。此外,肿瘤抗原特异性 CD4 T 效应细胞可以在各种肿瘤实体中维持抗肿瘤免疫反应,这表明肿瘤抗原特异性 CD4 Th1 细胞与 TAMs 之间的同源相互作用可能会使肿瘤内的 M1/M2 比值向 M1 倾斜。本研究通过广泛的基因和蛋白质表达分析表明,M2 样 PEC 在 MHC II 限制的与肿瘤特异性 CD4 Th1 细胞相互作用后发生了重新极化。此外,将 OVA 特异性 OT-II 细胞过继转移到表达 IA 肿瘤的 C57BL/6 小鼠中,导致 M1 样 TAMs 的积累增加,并增强了 M1 相关基因和蛋白表达谱。因此,本文强调了 CD4 Th1/TAM 轴在重新调节免疫抑制性肿瘤微环境方面的一个迄今为止被低估的功能。